In recent years, the chemokine receptor CXCR4 has been shown to be implemented in the mobilization of progenitor cells from the bone marrow. This fi nding has prompted a search for CXCR4 antagonists acting as stem cell mobilizing agents. In accordance, it is important to look into the molecular pharmacology of well-known CXCR4 antagonists in order to augment the potency and affi nity and to increase the specifi city of future CXCR4-targeting compounds. In this chapter, binding modes of CXCR4 antagonists that have been shown to mobilize stem cells are discussed. In addition, comparisons between results obtained from structure-function studies and fi ndings from newly released crystal structures are drawn.
CITATION STYLE
Steen, A., & Rosenkilde, M. M. (2012). Molecular pharmacology of CXCR4 inhibition. In Novel Developments in Stem Cell Mobilization: Focus on CXCR4 (pp. 23–35). Springer US. https://doi.org/10.1007/978-1-4614-1960-0_2
Mendeley helps you to discover research relevant for your work.